Mainz Biomed *Hot-Stock*
Development lab CM announces the following: Current non-invasive screening options miss most adenomas. Therefore, they are ineffective for prevention. This result is against the market leader and MB's sole competitor in the US, Exact Sciences.
Adenomas are early precancerous polyps that can lead to colorectal cancer and cannot be detected with current invasive blood tests and non-invasive test kits. This is exactly where MB comes in with the ColoFuture study (mRNA-based technology). If the result is positive and the integration into Colo Alert succeeds, it would be the absolute breakthrough in colon cancer screening for home use and a clear advantage over the TKit from Exact Sciences. This gives access to a huge market potential. Mainz Biomed Long!
Submitted August 05, 2022 at 03:51PM by carloschmidtasset
via reddit https://ift.tt/iDlyZeO